Posted On: 03/03/2014 12:51:57 AM
Post# of 11
BIOAF Recent News
biOasis Technologies to list its stock in OTCQX Marketplace in the US M2 - Tue Feb 25, 6:11AM CST
biOasis to Begin Trading on OTCQX(R) Marketplace in the U.S. Marketwire - Mon Feb 24, 8:05AM CST
biOasis to Begin Trading on OTCQX® Marketplace in the U.S. Marketwire Canada - Mon Feb 24, 8:02AM CST
biOasis Technologies Begins Trading on OTCQX® PR Newswire - Mon Feb 24, 6:00AM CST
Global Lithium Ion Battery Market to 2019: Cathode, Anode & Electrolytic Solution Analysis M2 - Thu Feb 13, 10:19AM CST
Urban Airship Reveals Industry's Current State of Mobile Maturity Marketwire - Thu Feb 13, 10:16AM CST
Option Grant-biOasis Technologies Inc. Marketwire - Wed Dec 04, 4:46PM CST
Study Demonstrates biOasis Technologies' Conjugate of Metastatic Cancer Drug, Herceptin, Penetrates Blood-Tumor Barrier 10 Times Greater Than Herceptin Alone Marketwire - Tue Nov 12, 8:05AM CST
biOasis Technologies to list its stock in OTCQX Marketplace in the US M2 - Tue Feb 25, 6:11AM CST
biOasis to Begin Trading on OTCQX(R) Marketplace in the U.S. Marketwire - Mon Feb 24, 8:05AM CST
biOasis to Begin Trading on OTCQX® Marketplace in the U.S. Marketwire Canada - Mon Feb 24, 8:02AM CST
biOasis Technologies Begins Trading on OTCQX® PR Newswire - Mon Feb 24, 6:00AM CST
Global Lithium Ion Battery Market to 2019: Cathode, Anode & Electrolytic Solution Analysis M2 - Thu Feb 13, 10:19AM CST
Urban Airship Reveals Industry's Current State of Mobile Maturity Marketwire - Thu Feb 13, 10:16AM CST
Option Grant-biOasis Technologies Inc. Marketwire - Wed Dec 04, 4:46PM CST
Study Demonstrates biOasis Technologies' Conjugate of Metastatic Cancer Drug, Herceptin, Penetrates Blood-Tumor Barrier 10 Times Greater Than Herceptin Alone Marketwire - Tue Nov 12, 8:05AM CST
(0)
(0)
